Regulatory Filings • Jul 3, 2023
Regulatory Filings
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information /*<![CDATA[*/ /**/ /**/ /**/ link{ color: blue }visited{ color: purple } .ah{size:595.3pt 841.9pt;margin:72.0pt 72.0pt 72.0pt 72.0pt;}div.ah{}p.be{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";text-align:right}span.bc{font-family:"Arial","sans-serif"}p.bf{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";text-align:center}span.az{font-family:"Arial","sans-serif";color:black}p.bg{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";text-align:justify}p.bh{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-top:0cm;margin-right:-9.4pt;margin-bottom: 0cm;margin-left:0cm;margin-bottom:.0001pt;line-height:normal}table.bi{width:467.8pt;margin-left:-7.1pt}td.av{width:225.65pt;padding:0cm 0cm 0cm 0cm} p.bj{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-top:0cm;margin-right:0cm;margin-bottom:0cm; margin-left:7.1pt;margin-bottom:.0001pt}td.au{width:242.15pt;padding:0cm 0cm 0cm 0cm}tr.aq{height:24.7pt}td.as{width:225.65pt;padding:0cm 0cm 0cm 0cm; height:24.7pt}p.bk{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-top:0cm;margin-right:0cm;margin-bottom:0cm; margin-left:7.1pt;margin-bottom:.0001pt;line-height:normal}td.ar{width:242.15pt;padding:0cm 0cm 0cm 0cm; height:24.7pt}p.bl{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-bottom:0cm;margin-bottom:.0001pt}p.bm{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-bottom:0cm;margin-bottom:.0001pt;text-align: justify;line-height:normal}p.bn{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-top:0cm;margin-right:-6.3pt;margin-bottom: 0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:justify;background:white}span.bo{font-size:11.0pt;font-family:"Arial","sans-serif"; color:black} p.bp{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-top:0cm;margin-right:-6.3pt;margin-bottom: 0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:justify;background:white}p.bq{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-top:0cm;margin-right:-6.3pt;margin-bottom: 0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:justify;background:white}p.br{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";text-align:justify;line-height:normal}p.bs{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";line-height:normal}span.aj{font-size:9.0pt;font-family:"Arial","sans-serif"} .fr-view-element{font-family: sans-serif;font-size: 12pt;line-height: 140%;padding: 20px;box-sizing: border-box;overflow-x: auto;min-height: 60px;text-align: left;margin-bottom: 10px;width: 837px;} .fr-view-element img{padding: 0 1px;} .fr-view-element .ah{margin: 63.8pt 1.6cm 62.35pt 1.6cm;} .fr-view-element p{font-size: 10pt;} /**/ /**/ /**/ /*]]>*/ ![]()
RNS Number : 6343E
Assura PLC
03 July 2023
3 July 2023
Assura plc
Change of Registered Office Address
Assura plc ("Assura" or "the Company"), the UK's leading primary care property investor and developer, announces that the Company's registered office address has changed to 3 Barrington Road, Altrincham, WA14 1GY with immediate effect.
In line with Assura's net zero carbon ambition, plans are in place to renovate and refurbish the building to minimise energy consumption, with works including window replacement, improvements to thermal insulation of the building fabric, enhanced building controls and extensive use of recycled materials where possible.
- ENDS -
For more information, please contact:
| Assura plc | Tel: 01925 945354 |
| David Purcell, Investor Relations Director | Email: [email protected] |
| FGS Global Gordon Simpson James Thompson |
Tel: 0207 251 3801 Email: [email protected] |
Notes to Editors
Assura plc is a national healthcare premises specialist and UK REIT based in Altrincham, UK - caring for more than 600 primary healthcare buildings, from which over six million patients are served.
A constituent of the FTSE 250 and the EPRA* indices, as at 31 March 2023, Assura's portfolio was valued at £2.7 billion.
At Assura, we BUILD for health. Assura builds better spaces for people and places, invests in skills and inspires new ways of working, and unlocks the power of design and innovation to deliver lasting impact for communities - aiming for six million people to have benefitted from improvements to and through its healthcare buildings by 2026.
Assura is leading for a sustainable future, targeting net zero carbon across its portfolio by 2040.
Further information is available at www.assuraplc.com
*EPRA is a registered trademark of the European Public Real Estate Association
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
CRODZGFVVGLGFZM
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.